Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB Study.

M R Cooper, O R McIntyre, K J Propert

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |September 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    89&#x2003;Influence of sperm preincubation on development and sex ratio of <i>in vitro</i>-produced bovine embryos.

    Reproduction, fertility, and development·2022
    Same author

    Implications of pretreatment incisor inclinations for the achievement of cephalometric normal values-a study on two patient collectives.

    Journal of orofacial orthopedics = Fortschritte der Kieferorthopadie : Organ/official journal Deutsche Gesellschaft fur Kieferorthopadie·2021
    Same author

    [Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein].

    Der Urologe. Ausg. A·2018
    Same author

    SULFATION PATHWAYS: Expression of <i>SULT2A1</i>, <i>SULT2B1</i> and <i>HSD3B1</i> in the porcine testis and epididymis.

    Journal of molecular endocrinology·2018
    Same author

    Coordinating bracket torque and incisor inclination : Part 2: Reproducibility and statistical measures of the torque coordination angle (TCA).

    Journal of orofacial orthopedics = Fortschritte der Kieferorthopadie : Organ/official journal Deutsche Gesellschaft fur Kieferorthopadie·2018
    Same author

    SULFATION PATHWAYS: Formation and hydrolysis of sulfonated estrogens in the porcine testis and epididymis.

    Journal of molecular endocrinology·2018

    For multiple myeloma patients, sequential alkylating agents showed poorer survival. Single-agent melphalan/prednisone is recommended for initial therapy due to simplicity and cost-effectiveness.

    Area of Science:

    • Hematology
    • Oncology
    • Clinical Pharmacology

    Background:

    • Multiple myeloma is a hematologic malignancy.
    • Intravenous (IV) alkylating agents are a cornerstone of multiple myeloma treatment.
    • Optimizing initial therapeutic regimens is crucial for patient outcomes.

    Purpose of the Study:

    • To compare the efficacy and toxicity of four different IV alkylating agent regimens in previously untreated multiple myeloma patients.
    • To evaluate the impact of treatment sequencing on patient survival.
    • To identify optimal initial therapy for multiple myeloma.

    Main Methods:

    • A randomized trial involving 615 previously untreated multiple myeloma patients.
    • Four treatment arms: combination (MCBP), sequential (Seq-MCBP), combination with doxorubicin (MCBPA), and single-agent IV melphalan (MP).

    Related Experiment Videos

  • All groups received tapering prednisone; toxicity and response were monitored.

    • Main Results:

    • Toxicity profiles were similar across regimens, with faster cytopenia nadir in the single-agent melphalan group.
    • Treatment response rates were comparable among all four regimens.
    • Significantly poorer survival was observed in the sequential alkylating agent group (Seq-MCBP).
    • Improved survival in azotemic patients with high tumor burden was noted with IV MP or IV MCBP.

    Conclusions:

    • Sequential administration of alkylating agents is associated with inferior survival in multiple myeloma.
    • Single-agent melphalan/prednisone (MP) offers a simple, cost-effective, and effective initial treatment option.
    • Consideration of melphalan/prednisone as first-line therapy for all multiple myeloma patients is warranted.